Evidence map›Paper›PMID 38403474›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Regioselective Arylation of Amidoaryne Precursors via Ag-Mediated Intramolecular Oxy-Argentation.

Yong-Ju Kwon, Ye-Jin Kong, Min-Jung Lee, Eun-Hye Lim, Jaesung Kwak, Won-Suk Kim

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yong-Ju KwonDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea.ORCID https://orcid.org/0000-0001-9517-7885
Ye-Jin KongDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea.ORCID https://orcid.org/0009-0003-8380-2091
Min-Jung LeeDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea.ORCID https://orcid.org/0009-0008-7853-0673
Eun-Hye LimDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea.ORCID https://orcid.org/0009-0004-7074-9225
Jaesung KwakInfectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, 34114, Republic of Korea.ORCID https://orcid.org/0000-0001-8010-7307
Won-Suk KimDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea.ORCID https://orcid.org/0000-0001-9180-4570

Funding

Basic Science Research ProgramKorea Research Institute of Chemical Technology KK2332-10National Research Foundation of Korea NRF-2021R1A6A1A10039823National Research Foundation of Korea NRF-2022R1F1A1074510
6 · The paper itself

Abstract

An unprecedented silver-mediated intramolecular oxy-argentation of 3-amidoaryne precursors that quickly generates a heteroarylsilver species is developed. AgF acts as both a stoichiometric fluoride source and a reagent for the formation of a benzoxazolylsilver intermediate via aryne generation. Pd-catalyzed coupling reactions of (hetero)aryl iodides with a silver species, generated in situ, allow for the synthesis of various C7-arylated benzoxazoles. As a result, an aryl group is selectively introduced into the meta-position of 3-amidobenzyne precursors. Mechanistic studies have indicated the presence of a benzoxazolylsilver intermediate and revealed that the reaction proceeds via an intramolecular oxy-argentation process, which is initiated by a direct fluoride attack on the silyl group.

Indexed as

amidobenzyne precursorsarynebimetallic cross‐couplingoxy‐argentationregioselective arylation

Identifiers

PMID38403474
PMCPMC11077674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.